C-Diff: Could a vaccine prevent this contagious killer?
Tuesday, July 11, 2017
Clostridium difficile (C-diff) is a bacterial infection that causes abdominal pain, fever and diarrhea. The symptoms may range from mild to severe and can lead to death. C-diff is the leading cause of gastroenteritis-associated death and was estimated to cause 14,000 deaths in 2007 in the United States according to the New England Journal of Medicine.
C-diff is highly contagious and can live on surfaces for up to 90 days. Only cleaners with chlorine bleach are effective in reducing the risk of contamination from C-diff infected surfaces. This bacterial infection seems to be more prevalent in females than males, higher among whites than nonwhites and there is a higher incidence in persons >65 years and older.
This same study in the New England Journal of Medicine noted health care associated C-diff infections more prevalent than community associated C-diff infections and it was estimated that 453,000 cases of C-diff occurred in 2011 in the United States. This study also concluded health care associated C-diff infections continue to be an ongoing issue with reoccurrence and death more common among health-care associated infections than community associated infections. However, most patients with C-diff had inpatient or outpatient health care exposure before onset of the infection. According to this study, the estimated death total from C-diff nationally in 2011 was 29,000 with the majority among patients with health care associated infections.
There are no cures for C-diff and treatment can include antibiotic therapy which may worsen the C-diff or as a last resort fecal transplant or surgery. Continued research needs to be done to find vaccinations and better treatment options for C-diff. Sterling Research is currently conducting a study to test a vaccination for this contagious bacterial infection. If you would like to learn more, please call our office and speak to a recruitment coordinator.
References: Lessa, F.C., Mu, Y., Bamberg, W.M., Beldavs, Z. G., Dumyati, G.K., Dunn, J.R., Farley, M.M., Holzbauer, S.M., Meek, J.I., Phipps, E.C., Wilson, L.E., Winston, L.G., Cohen, J.A., Limbago, B.M., Fridkin, S.K., Gerding, D.N., McDonald, L.C., The New England Journal of Medicine (February 26, 2015), Burden of Clostridium difficile Infection in the United States, 372;9
Subscribe To Our Blog
07/11/2017 - C-Diff: Could a vaccine preven
03/23/2017 - New Drug Prevents Heart Attack
06/07/2016 - Meningitis: More than just a “
02/29/2016 - One Decade Later, HPV Vaccine
05/22/2015 - The Truth About Insulin
05/22/2015 - Diabetes Clinical Research
05/12/2015 - Osteoarthritis
05/04/2015 - What can I do about Acne?
02/18/2015 - Yet Another "Cutting Edge" Med
01/26/2015 - Recent study of an investigati
12/03/2014 - It Is Estimated That 1 in 3 Am
12/02/2014 - Making a positive impact on th
10/28/2014 - Happy Birthday wishes to Dr. J
08/15/2014 - Monoclonal Antibodies Revoluti
07/09/2013 - Swimmer's Ear - What You Need
05/17/2013 - Pink Eye: Usually Mild and Eas
05/05/2013 - High Triglycerides - What You
03/13/2013 - UK Researchers Dispel Myths of
06/14/2012 - Why Do Research In Children?
01/13/2010 - Should Your Child Be in a Clin
05/09/2008 - Med Hero Campaign TV Spot